Takeda to acquire Ariad in $5.2 billion deal
January 9, 2017Manufacturing and Production, Sales and Marketing Ariad, Takeda
Takeda has acquired US drug maker, Ariad Pharmaceuticals, in a deal worth $5.2 billion. Takeda has been looking to bolster …
Abbott completes $25 billion deal for St. Jude
January 9, 2017Sales and Marketing Abbott, St. Jude
It has been announced that the Federal Trade Commission has approved Abbott Laboratories acquisition of St. Jude Medical for $25 …
Pharmafile.com’s top ten most popular articles of 2016
January 9, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
Happy New Year from us here at Pharmafocus! As we leave 2016 behind, take a look at ten of its …
Amgen and Immatics enter $1bn immuno-oncology partnership
January 9, 2017Research and Development, Sales and Marketing Amgen, immatics, immunotherapy
Amgen has announced it is to join forces with cancer immunotherapy biotech Immatics Biotechnologies in a partnership potentially worth over …
Merrimack sells off drug for $1 billion and cuts workforce by 80%
January 9, 2017Sales and Marketing Onivyde, ipsen, merrimack
Ipsen has announced the agreement to acquire oncology assets from Merrimack Pharmaceuticals, most notably the pancreatic cancer drug Onivyde, in …
Roche’s Tecentriq scores another bladder cancer Priority Review
January 9, 2017Sales and Marketing Roche, bladder cancer, tecentriq
Roche has announced that its immunotherapy drug Tecenetriq (atezolizumab) has been awarded Priority Review by the FDA for the treatment …
Targovax promotes new CFO
January 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targovax
Erik Digman Wiklund has been named as the new chief financial officer (CFO) of Norwegian biotech Targovax, replacing Oystein Soug …
Pfizer announce positive results for Humira biosimilar
January 6, 2017Medical Communications, Research and Development, Sales and Marketing Humira, Pfizer, biosimilar
Pfizer has released the successful Phase 3 results to its biosimilar to AbbVie’s blockbuster Humira, meeting its primary endpoint in …
Top Ten most popular articles on Pharmafile.com this week
January 6, 2017Medical Communications biggest news, biggest stories, top 10, top 10 stories, top stories, top ten
The start of 2017 has already had some big stories hit the news, with many companies taking the opportunity to …
Novartis and Ionis enter $1bn cardiovascular drug deal
January 6, 2017Medical Communications, Research and Development, Sales and Marketing Akcea, Akcea Therapeutics, Ionis, Ionis Pharmaceuticals, cardiovascular
Ionis Pharmaceuticals and one of its wholly-owned subsidiaries Akcea Therapeutics have entered into a partnership with Novartis worth potentially more …
Insider interview: Roche discusses the importance of sustainability in pharma manufacturing
January 6, 2017Manufacturing and Production, Medical Communications Roche
Peter Schurrenberger, Chief Safety, Health and Environment Officer at Roche, discusses their recent recognition as a leader for corporate action …
New research reveals how cancer cells grow and spread through body
January 6, 2017Medical Communications Cancer, Cancer Research UK, ICR, Institute of Cancer Research, cancer research, cell movement
Research conducted by The Institute of Cancer Research (ICR), co-funded by Cancer Research UK, has discovered how cancer cells are …
AstraZeneca acquires biotech’s unique antithrombotic drug
January 5, 2017Medical Communications, Sales and Marketing APT, AstraZeneca, acquisition
AstraZeneca has announced that it has entered into a research collaboration, option and asset purchase agreement with APT Therapeutics, a …
Wockhardt’s Gujarat plant hit with FDA warning letter
January 5, 2017Manufacturing and Production FDA, Wockhardt
Indian pharma and biotech firm Wockhardt has been accused of violating current good manufacturing practice (CGMP) regulations in a letter …
Morning sickness pill scientific backing called into question
January 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diclectin, Diclegis, Duchesnay, FDA, kim kardashian, morning sickness
Many women suffer from morning sickness during the early stages of pregnancy and some suffer from hyperemesis gravidarum, acute morning …
Philippine FDA orders Sanofi to pull dengue vaccine ads
January 5, 2017Medical Communications, Sales and Marketing Philippines, Sanofi, Vaccine, dengue, virus
Sanofi has suffered a major blow to its dengue immunisation programme in the Philippines after it was requested the company …
FDA steps up fight against superbugs with livestock ruling
January 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Antibiotics, FDA, Guidelines, Livestock, agriculture, antibiotic resistance, farmers
The FDA began the year by announcing the implementation of ‘Guidance for Industry #213’. The new rule is a voluntary …
Gilead makes move in oncology by snaffling Riva from Novartis
January 4, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Novartis, oncology
Gilead Sciences have made an ambitious move to boost its oncology business by appointing current head of global oncology development …
Inotek’s glaucoma lead candidate falls at Phase 3 trial
January 4, 2017Research and Development Glaucoma, inotek, inotek pharma
Inotek Pharmaceutical announced that its lead candidate, trabodenoson, a drug designed to treat glaucoma, had failed to outperform placebos in …
Blast at Sun Pharma factory kills two
January 4, 2017Medical Communications, Research and Development Sun Pharma, factory, fire
A blast at Sun Pharma’s Ahmednagar factory caused the deaths of two workers and injured a further two. The four …
Latest content
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
